Codeine Cough Syrup Under Fire as FDA Scrutinizes Use for Children

The FDA is ramping up its examination of safety concerns surrounding the use of cough syrups containing codeine for children under the age of 12. An announcement posted on the regulatory agency’s website on Wednesday highlighted its concerns: “We are evaluating all available information and will also consult with external experts by convening an advisory.
Read more: http://ift.tt/1IWlsZZ